Mark Your Calendar: SpaceX Could Be a Very Different Stock by Halloween

SpaceX’s IPO was heavily oversubscribed, with demand reported at 2x authorized supply on June 5 and potentially 4x by the June 12 offering date, while less than 5% of shares were initially available for public trading. The stock’s float is expected to expand materially, with publicly traded shares set to roughly double by the end of August 2026 and one-third unlocked by the end of October, creating a key supply overhang and catalyst. The article remains constructive on the IPO’s success but warns that future price action will depend on both lockup dynamics and business performance.

Analysis

The setup is less about fundamental discovery and more about a mechanically supported scarcity trade that can persist until the float meaningfully expands. In the near term, index inclusion creates a forced-buyer window while public supply is still extremely constrained, which can keep implied borrowing costs elevated and make spot price behavior look stronger than underlying institutional conviction. That matters because when tradable supply is this thin, even modest incremental demand can overwhelm the tape and amplify momentum.

The real risk is not an immediate post-IPO collapse; it is a staggered supply overhang that can convert a narrative-driven squeeze into a distribution event over the next 2-6 months. As unlocks start to matter, the marginal seller is likely to be a different constituency than the IPO buyer, and that typically changes order flow quality fast. The market will also begin to reprice the name on a “sellable shares x valuation” basis rather than a pure story premium, which can compress multiple support even if operations remain strong.

Second-order winners are less obvious: the new benchmark inclusion can create temporary tracking error for passive funds and systematic funds, while high-beta growth peers may see sympathy flows if investors treat the IPO as a halo indicator for private-market re-ratings. The contrarian view is that the most crowded part of the trade may be the expectation of inevitable post-lockup weakness; if management uses staggered unlocks to telegraph orderly sales and the business prints well, supply may be absorbed faster than skeptics expect. Still, that scenario depends on continued top-line execution; any miss against elevated expectations would likely hit a thin float disproportionately hard.

Key Decisions for Investors

• Short-dated tactical long via call spreads on NDAQ into the fast-entry inclusion window, then monetize into the first unlock dates; the edge is in forced buying, not multi-month ownership.
• Avoid initiating outright longs in the IPO after the first inclusion-driven pop; if you want exposure, use a pair trade: long the broad index beneficiary basket vs short the IPO on a 1-3 month horizon to isolate float-scarcity reversal risk.
• Consider a put spread structure 60-120 days out to express the view that staggered unlocks will pressure the name once supply expands; target entry only after the first supply-driven squeeze exhausts.
• For relative-value growth exposure, overweight NFLX/NVDA on any sympathy bid rather than chasing the new issue; both names have proven post-IPO scarcity analogs and deeper institutional sponsorship, which makes their flows cleaner than a newly listed float-constrained story.
• If the stock stays pinned through the next unlock, switch from directional short to event-driven: sell call credit spreads against a core short only after borrow stabilizes, because the most likely failure mode is not collapse but a slow bleed punctuated by squeezes.